Skip to content

Investigator

Jing Yang

UNIVERSITY OF CALIFORNIA, SAN DIEGO · funded by NCI, NIEHS, NHLBI

Companies
2

Resolved onto their grants.

Grants
12

Federal awards on file.

Non-dilutive funding
$5.7M

Summed across those awards.

First award
Mar 1, 1993

Latest Aug 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Regulation of Tumor Invasion and Metastasis by Matrix Stiffness

    $437k

    Aug 1, 2025NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11334587 (opens the source filing in a new tab)

  2. R01

    Cytoplasmic remodeling during the vertebrate oocyte-to-embryo transition

    $627k

    Jan 24, 2025NIEHSUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGNNIH RePORTER · 11049710 (opens the source filing in a new tab)

  3. R01

    Cytoplasmic remodeling during the vertebrate oocyte-to-embryo transition

    $613k

    Jan 24, 2025NIEHSUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGNNIH RePORTER · 11262885 (opens the source filing in a new tab)

  4. R44

    Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis

    $1.1M

    Sep 15, 2022NHLBIAPLEXIS, INC.NIH RePORTER · 11051837 (opens the source filing in a new tab)

  5. R01

    Functional interplay between Hippo and estrogen receptor ESR1

    $434k

    Mar 1, 2022NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11042246 (opens the source filing in a new tab)

  6. R01

    Functional interplay between Hippo and estrogen receptor ESR1

    $434k

    Mar 1, 2022NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11296882 (opens the source filing in a new tab)

  7. R35

    Intracellular Remodeling during Early Development

    $476k

    Jul 1, 2019NIGMSUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGNNIH RePORTER · 11252306 (opens the source filing in a new tab)

  8. R01

    Regulation of Tumor Invasion and Metastasis by Matrix Stiffness

    $364k

    Aug 1, 2015NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11006267 (opens the source filing in a new tab)

  9. R01

    Regulation of Tumor Invasion and Metastasis by Matrix Stiffness

    $51k

    Aug 1, 2015NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11378902 (opens the source filing in a new tab)

  10. R01

    Regulation of Tumor Invasion and Metastasis by Matrix Stiffness

    $364k

    Aug 1, 2015NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11264836 (opens the source filing in a new tab)

  11. P30

    Cancer Biology and Signaling Program

    $90k

    Jul 1, 1996NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11335311 (opens the source filing in a new tab)

  12. T32

    Contemporary Approaches to Cancer Cell Signaling and Communication

    $674k

    Mar 1, 1993NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11099666 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources